← All tickers

Is ALT Worth Buying in 2026?

Altimmune, Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-07

Here’s whether Altimmune, Inc. Common Stock (ALT) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: RSI 43 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-3.21% over 10 days); weak 1-year return of -50.4%; 3-month momentum negative (-30.1%). Currently 64.9% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

ALT is trading below its 200-day MA ($3.93) — a key warning sign the longer-term trend is under pressure. An RSI of 42.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -50.4% compares to +24.4% for SPY (trailed the market by 74.7%). The current 64.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $4,963 today
vs. S&P 500 (SPY) — same period trailed market by 74.7%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($3.93)
✗Above 50-day MA ($3.06)
✓RSI(14) neutral zone (30–70) — currently 42.7
✗Positive return (-50.4%)
!Within 10% of period high (−64.9%)
Period Range $2.71
$2.56 $7.73
RSI (14) 42.7
0 · OversoldOverbought · 100

Key Metrics

Price$2.71
Period Return-50.4%
Period High$7.73
Period Low$2.56
Drawdown−64.9%
MA-50$3.06
MA-200$3.93
RSI (14)42.7
Avg Volume (30d)3.8M
vs. SPYtrailed by 74.7%
Return Rank#1084 of 1245

Trade ALT

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers